@HotKidneyAction profile picture
Jim Moriarty @HotKidneyAction

Kidney Doctor, Gloucester @GlosRenal & Forest of Dean. 🦋@hotkidneyaction.com

Joined July 2015
  • Tweets 2,006
  • Following 165
  • Followers 1,074
318 Photos and videos
Two out of three talks in AI sessions coming across as heavily AI influenced - Difficult question? Immediate answer. Declarative statement - hyphenated chaser. Rule. Of. Three. #ERA26
32
I break this account out of hibernation for this at #ERA26. See you all next year!
1
4
85
Jim Moriarty retweeted
Arvind singh@Arvind__
10 Jan 2025
Replying to @GlosRenal
@GlosRenal @gloshospitals We are super excited to announce the first SOUTH-WEST 🇬🇧Glomerulonephritis 🫘 Day. With an amazing group of National/International expert panelist & speakers we look forward to see you there. @RCP approved with 6 CPD points.
1
11
20
1,456
Jim Moriarty retweeted
Nephrology Journal Club@NephJC
12 Nov 2024
See you on the other side 🦋 nephjc.com/news/2024/11/12/t… #NephJC #NephSky #SkyNeph
1
14
38
8,534
Jim Moriarty retweeted
Will Herrington@willkidney
25 Oct 2024
EMPA-KIDNEY post-trial f-up has revealed helpful findings on #SGLT2i in #CKD. We hope residual uncertainties r resolving & more pts r treated early & long-term. Deep gratitude to 1600 collaborators & 6609 pts.#KidneyWk @NatalieStaplin @RichardHaynes3 @MartinLandray @Oxford_NDPH
NEJM
@NEJM
25 Oct 2024
Presented at #KidneyWk: Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: nej.md/3NE3W7K
A Kaplan–Meier plot of progression of kidney disease or death from cardiovascular causes (composite primary outcome) in the empagliflozin group and the placebo group during the combined active- and post-trial periods.

ALT A Kaplan–Meier plot of progression of kidney disease or death from cardiovascular causes (composite primary outcome) in the empagliflozin group and the placebo group during the combined active- and post-trial periods.

2
24
73
12,816
EMPAKIDNEY post trial extended follow up from @willkidney - sustained and meaningful improvements in cardiovascular and renal outcomes #KidneyWk nejm.org/doi/full/10.1056/NE…

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease | NEJM

In the EMPA-KIDNEY trial, empagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, had positive cardiorenal effects in patients with chronic kidney disease who were at risk for disease pr...

nejm.org
2
195
Looks like Hiddo Heerspink and team have opened the door to use of GLP1a for renal protection in proteinuric non-diabetic kidney disease… #KidneyWk nature.com/articles/s41591-0…
132
Love to know how they came up with the name for the Kidney Action team #kidneywk
1
137
🚨🚨Room 6a Right Now 🚨🚨#KidneyWk
2
1
10
866
Lovely few days in #Edinburgh for #UKKW2024, and looking forward to some informal network building opportunities in Bournemouth #UKKW2025 open.spotify.com/track/50VJq…

Born Slippy - NUXX

Underworld · Trainspotting (Original Motion Picture Soundtrack) · Song · 1996

open.spotify.com
1
5
340
Two great challenges from Morgan Grams @meg21212 at #UKKW2024 - 1. Be sure our higher risk patients get access to the drugs they need - 2. Base decisions in lower risk patients on individualised absolute risk reduction - RAASi might be enough! ckdpc.org/risk-models.html
4
4
1,453
#UKKW2024
1
1
10
1,558
Ellis - #realisticmedicine programme - balancing patient priorities, effective interventions and cost across NHS in Scotland realisticmedicine.scot #UKKW2024

1
1
284
Wonderful tributes to @donalnhs to introduce his named lecture at #UKKW2024, from both his wife Marie O’Donoghue and speaker Sharlene Greenwood. A true champion of the MDT at the centre of kidney care. Here’s the time he got hold of my phone at #UKKW2014
1
4
12
1,111
Jim Moriarty retweeted
Dr Hannah Young@hmlyoungphysio
11 Jun 2024
Professor Bruce Gutherie- only 2% on people with CKD don’t live with another condition #ukkw2024
2
7
21
1,745
So proud of this team.
Gloucester Renal@GlosRenal
23 Apr 2024
Medical PD insertion up and running again!
1
9
676
That's pretty much a wrap for #UKKW2023. See you all at #UKKW2024, wherever it might be...

ALT Trainspotting 1996 GIF

2
6
969
Big takeaway for me from #UKKW2023 (from multiple sessions, @IgAN_JBarratt and others) - substantial risk of progression of IGAN to ESRD even in groups who might be considered low risk - borderline CKD, minimal proteinuria.
1
5
568
Frailty interventions - KOKU project - sounds pretty similar to what we already have through @beam_kidney, well embedded in the kidney community - what am I missing? kokuhealth.com/ #UKKW2023

Welcome - KOKU Health

kokuhealth.com
1
3
349
Frailty - @adamgordon1978 - low-cost systematic method for scoring frailty through EPR #UKKW2023 thelancet.com/journals/lance…

Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care...

The Hospital Frailty Risk Score provides hospitals and health systems with a low-cost, systematic way to screen for frailty and identify a group of patients who are at greater risk of adverse...

thelancet.com
214
Load more